deferoxamine has been researched along with Glomerulosclerosis, Focal Segmental in 3 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| van Swelm, RPL | 1 |
| Beurskens, S | 1 |
| Dijkman, H | 1 |
| Wiegerinck, ETG | 1 |
| Roelofs, R | 1 |
| Thévenod, F | 1 |
| van der Vlag, J | 1 |
| Wetzels, JFM | 1 |
| Swinkels, DW | 1 |
| Smeets, B | 1 |
| Keane, WF | 1 |
| O'Donnell, MP | 1 |
| Kasiske, BL | 1 |
| Kim, Y | 1 |
| Kawamoto, S | 1 |
| Kawamura, T | 1 |
3 other studies available for deferoxamine and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Kidney tubule iron loading in experimental focal segmental glomerulosclerosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Deferoxamine; Disease Models, Animal; | 2022 |
Oxidative modification of low-density lipoproteins by mesangial cells.
Topics: Antioxidants; Arachidonic Acid; Butylated Hydroxytoluene; Catalase; Cell Division; Cells, Cultured; | 1993 |
[A role for reactive oxygen species in the pathogenesis of focal glomerulosclerosis].
Topics: Animals; Deferoxamine; Glomerulosclerosis, Focal Segmental; Macrophages; Male; Rats; Rats, Sprague-D | 1996 |